Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × sotorasib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 5 Colorectal Neoplasms 3 Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation 2 Venous Thromboembolism 1 Sexual Dysfunction, Physiological 1 Pancreatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Non Small Lung Cancer 1 Neoplasms 1 Eunuchism 1 Erectile Dysfunction 1 Efficacy 1 Brain Neoplasms 1

Interventions

Radiosurgery 113 Temozolomide 104 Bevacizumab 70 Radiotherapy 66 Magnetic Resonance Spectroscopy 66 Carboplatin 29 pembrolizumab 27 Irinotecan 26 Surgical Procedures, Operative 25 Nivolumab 23 Radiation 22 Etoposide 22 Magnetic Resonance Imaging 21 Ipilimumab 21 Erlotinib Hydrochloride 21 Cyclophosphamide 21 Surveys and Questionnaires 19 Aminolevulinic Acid 18 Specimen Handling 16 Pemetrexed 16 Mental Status and Dementia Tests 16 Cisplatin 16 Carmustine 15 Topotecan 14 Trastuzumab 13 Saline Solution 12 Neuropsychological Tests 12 Filgrastim 11 Drug Therapy 11 Dexmedetomidine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06807619 2025-05-22

A Study of Sotorasib in People With Brain Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡